At ESCRS 2025, Prof. Henny Beckers shares how canaloplasty with iTrack™ Advance went from something she was “a little bit afraid” to try, to an early go-to step in her glaucoma treatment approach. Starting from a background in stenting, she now sees the value of working with patient physiology to treat the underlying causes of glaucoma, while also keeping future treatment options open.
She explains how SLT, MIGS and iTrack Advance fit into her mission to treat glaucoma earlier, reduce drop burden, protect quality of life and preserve sight for as long as possible. Along the way, she highlights the importance of working with an industry partner that is enthusiastic, open to discussion and focused on what really matters to surgeons and patients.
Learn more at itrack-advance.com.
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
